4IOI
Meditope-enabled trastuzumab in complex with CQFDLSTRRLKC
Entity
| Entity ID | Chain ID | Description | Type | Chain length | Formula weight | Number of molecules | DB Name (Accession) | Biological source | Descriptive keywords |
| 1 | A (A) | Trastuzumab light chain | polymer | 214 | 23502.0 | 1 | Homo sapiens | ||
| 2 | B (B) | Trastuzumab heavy chain | polymer | 223 | 23774.6 | 1 | Homo sapiens | ||
| 3 | C (H) | Immunoglobulin G-binding protein A | polymer | 55 | 6124.6 | 1 | UniProt (P0A015) Pfam (PF02216) | Staphylococcus aureus | IgG-binding protein A, Staphylococcal protein A |
| 4 | D (E) | Protein L | polymer | 65 | 6994.7 | 1 | UniProt (Q51918) Pfam (PF02246) | Finegoldia magna | |
| 5 | E (C) | meditope | polymer | 12 | 1472.8 | 1 | |||
| 6 | F, G, H, I, J (A, B, H, E, C) | water | water | 18.0 | 541 | Chemie (HOH) |
Sequence modifications
H: 4 - 54 (UniProt: P0A015)
E: 20 - 81 (UniProt: Q51918)
| PDB | External Database | Details |
|---|---|---|
| Ser 0 | - | expression tag |
| Gly 1 | - | expression tag |
| Ser 2 | - | expression tag |
| Tyr 3 | - | expression tag |
| PDB | External Database | Details |
|---|---|---|
| Ser 17 | - | expression tag |
| Gly 18 | - | expression tag |
| Ser 19 | - | expression tag |
| Ile 34 | Thr 490 | engineered mutation |
| Ala 55 | Asp 511 | engineered mutation |
| Asn 73 | Tyr 529 | engineered mutation |
| His 74 | Thr 530 | engineered mutation |
| Met 75 | Ile 531 | engineered mutation |
Sequence viewer
Contents of the asymmetric unit
| Polymers | Number of chains | 5 |
| Total formula weight | 61868.8 | |
| All* | Total formula weight | 61868.8 |






